Tower Research Capital LLC (Trc) Anixa Biosciences Inc Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,799 shares of ANIX stock, worth $5,684. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,799

Previous 1,483 21.31%

Holding current value

$5,684

Previous $4,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$2.48 - $3.97 $783 - $1,254	316 Added 21.31%	1,799 $4,000
Q3 2024 Nov 14, 2024	SELL	$2.21 - $3.48 $10,820 - $17,038	-4,896 Reduced 76.75%	1,483 $4,000
Q2 2024 Aug 13, 2024	BUY	$2.21 - $3.35 $1,865 - $2,827	844 Added 15.25%	6,379 $14,000
Q1 2024 May 15, 2024	BUY	$3.08 - $5.02 $8,722 - $14,216	2,832 Added 104.77%	5,535 $17,000
Q4 2023 Feb 13, 2024	SELL	$2.85 - $4.19 $37,221 - $54,721	-13,060 Reduced 82.85%	2,703 $10,000
Q3 2023 Nov 14, 2023	BUY	$2.97 - $3.87 $37,410 - $48,746	12,596 Added 397.73%	15,763 $51,000
Q2 2023 Aug 14, 2023	SELL	$3.0 - $5.97 $678 - $1,349	-226 Reduced 6.66%	3,167 $10,000
Q1 2023 May 09, 2023	BUY	$3.86 - $5.0 $12,313 - $15,950	3,190 Added 1571.43%	3,393 $14,000
Q4 2022 Feb 10, 2023	BUY	$3.78 - $5.81 $767 - $1,179	203 New	203 $1,000
Q2 2022 Aug 15, 2022	SELL	$2.55 - $4.1 $11,554 - $18,577	-4,531 Reduced 75.73%	1,452 $4,000
Q1 2022 May 12, 2022	BUY	$2.5 - $3.42 $7,650 - $10,465	3,060 Added 104.69%	5,983 $16,000
Q4 2021 Feb 14, 2022	SELL	$2.88 - $5.5 $1,186 - $2,266	-412 Reduced 12.35%	2,923 $9,000
Q3 2021 Nov 15, 2021	SELL	$3.57 - $5.6 $59,419 - $93,206	-16,644 Reduced 83.31%	3,335 $16,000
Q2 2021 Aug 16, 2021	BUY	$3.46 - $4.92 $69,127 - $98,296	19,979 New	19,979 $77,000
Q1 2021 May 17, 2021	SELL	$3.27 - $7.14 $46,492 - $101,516	-14,218 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.94 - $3.19 $19,997 - $32,882	10,308 Added 263.63%	14,218 $44,000
Q3 2020 Nov 16, 2020	SELL	$1.79 - $3.3 $4,621 - $8,520	-2,582 Reduced 39.77%	3,910 $10,000
Q2 2020 Aug 13, 2020	BUY	$1.53 - $3.06 $2,034 - $4,069	1,330 Added 25.77%	6,492 $20,000
Q1 2020 May 15, 2020	SELL	$1.35 - $4.06 $1,289 - $3,877	-955 Reduced 15.61%	5,162 $8,000
Q4 2019 Feb 07, 2020	BUY	$2.78 - $4.03 $14,483 - $20,996	5,210 Added 574.42%	6,117 $20,000
Q3 2019 Nov 05, 2019	BUY	$3.53 - $4.7 $2,463 - $3,280	698 Added 333.97%	907 $4,000
Q2 2019 Aug 13, 2019	SELL	$3.47 - $4.75 $2,741 - $3,752	-790 Reduced 79.08%	209 $1,000
Q1 2019 May 14, 2019	SELL	$3.85 - $5.53 $1,436 - $2,062	-373 Reduced 27.19%	999 $5,000
Q4 2018 Feb 14, 2019	BUY	$3.37 - $6.59 $4,623 - $9,041	1,372 New	1,372 $5,000

Others Institutions Holding ANIX

# of Institutions

Shares Held

5.73M

Call Options Held

7.1K

Put Options Held

26.7K

View Full List

About Anixa Biosciences Inc

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $96.9M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

More about ANIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Anixa Biosciences Inc Transaction History